Literature DB >> 19387960

Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.

Olga Trojnarska1, Adrian Gwizdała, Sławomir Katarzyński, Agnieszka Katarzyńska, Andrzej Szyszka, Magdalena Lanocha, Stefan Grajek, Lucyna Kramer.   

Abstract

BACKGROUND: Adult patients with congenital heart disease (CHD) usually find their exercise capacity satisfactory. However, objective evaluation is important for diagnostic and prognostic purposes. The aim of this study was to evaluate exercise capacity using cardiopulmonary exercise tests and measurement of serum B-type natriuretic peptide (BNP) levels in adult patients with CHDs, both in the entire study cohort and in subjects with individual types of cardiac lesions, as well as to verify the relation between BNP level and cardiac performance.
METHODS: The study group included 265 patients (136 males; mean age 34.4 +/- 11.6 years) 173 of whom were operated on at the mean age of 9.2 +/- 7.3 years. They represented the following types of CHD: 72 patients--surgically corrected coarctation of the aorta, 62--surgically corrected tetralogy of Fallot, 28--Ebstein anomaly, 26--patent atrial septal defect, 24--Eisenmenger syndrome, 20--uncorrected or palliated complex cyanotic lesions, 11--corrected transposition of the great arteries (TGA), 14--TGA after Senning operation, and 8--common ventricle after Fontana operation. The control group consisted of 39 healthy individuals (17 males) with a mean age of 35.8 +/- 9.3 years.
RESULTS: According to NYHA classification, 207 patients were recognized as representing class I symptoms, 47 subjects class II, and 11 class III. Cardiopulmonary exercise revealed significantly reduced exercise capacity in adults with CHD in general, compared to control subjects: maximal oxygen uptake (VO2max) was 23.3 +/- 6.9 vs. 33.6 +/- 7.2 mL/kg/min, respectively (p = 0.00001); maximum heart rate at peak exercise (HRmax) -161.1 +/- 33.2 vs. 179.6 +/- 12.3 bpm (p = 0.00001); respiratory workload (VE/VCO2slope) - 35.7 +/- 9.7 vs. 26.3 +/- 3.1 (p = 0.00001); and forced vital capacity (FVC) - 3.8 +/- 1.1 vs. 4.6 +/- 0.7 L (p = 0.00003). Various degrees of peak VO2max reduction were observed across the spectrum of CHD. Patients after repair of aortic coarctation demonstrated the highest VO2max (26.8 +/- 6.6 mL/kg/min), and the lowest was demonstrated by patients with Eisenmenger syndrome (12.8 +/- 4.8; ANOVA p = 0.00001). Serum BNP levels in the study group were higher than in the controls: 55.4 +/- 67.5 vs. 13.9 +/- 13.7 pg/mL, respectively (p = 0.00001). Various degrees of BNP level increase were found across the spectrum of CHD. Patients after repair of aortic coarctation demonstrated the lowest BNP level (24.8 pg/mL), and the highest level was found in patients with cyanotic defects (120.7 pg/mL; ANOVA p = 0.00001). BNP levels across the NYHA classes were as follows: I--35.7 pg/mL, II--94.1 pg/mL, and III--225.6 pg/mL. BNP levels showed negative correlation with VO2max (r = -0.525, p = 0.0001), FVC (r = -0.349, p = 0.00001), FEV1 (r = -0.335, p = 0.00001), and positive correlation with VE/VCO2slope (r = 0.447, p = 0.00001).
CONCLUSIONS: The exercise capacity of patients with CHD is, in general, compromised, most strikingly in patients suffering from pulmonary hypertension and cyanosis. Serum BNP levels in these subjects are increased and correlate well with exercise capacity. BNP level is higher in patients with cyanotic CHDs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19387960

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  9 in total

1.  Cardiopulmonary Exercise Testing-A Valuable Tool, Not Gatekeeper When Referring Patients With Adult Congenital Heart Disease for Transplant Evaluation.

Authors:  Jonathan N Menachem; Nosheen Reza; Jeremy A Mazurek; Danielle Burstein; Edo Y Birati; Arieh Fox; Yuli Y Kim; Maria Molina; Sara L Partington; Monique Tanna; Lynda Tobin; Joyce Wald; Lee R Goldberg
Journal:  World J Pediatr Congenit Heart Surg       Date:  2019-03-04

Review 2.  Exercise: friend or foe in adult congenital heart disease?

Authors:  Oktay Tutarel; Harald Gabriel; Gerhard-Paul Diller
Journal:  Curr Cardiol Rep       Date:  2013-11       Impact factor: 2.931

3.  Exercise Capacity in Children and Adolescents With Congenital Heart Disease: A Systematic Review and Meta-Analysis.

Authors:  Yenny Villaseca-Rojas; Javiera Varela-Melo; Rodrigo Torres-Castro; Luis Vasconcello-Castillo; Guillermo Mazzucco; Jordi Vilaró; Isabel Blanco
Journal:  Front Cardiovasc Med       Date:  2022-05-04

Review 4.  Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease.

Authors:  Saurabh Rajpal; Laith Alshawabkeh; Alexander R Opotowsky
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

5.  Survival data and predictors of functional outcome an average of 15 years after the Fontan procedure: the pediatric heart network Fontan cohort.

Authors:  Andrew M Atz; Victor Zak; Lynn Mahony; Karen Uzark; Peter Shrader; Dianne Gallagher; Stephen M Paridon; Richard V Williams; Roger E Breitbart; Steven D Colan; Jonathan R Kaltman; Renee Margossian; Sara K Pasquali; Kerstin Allen; Wyman W Lai; Rosalind Korsin; Bradley S Marino; Nicole Mirarchi; Brian W McCrindle
Journal:  Congenit Heart Dis       Date:  2014-06-17       Impact factor: 2.007

Review 6.  The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

Authors:  Massimiliano Cantinotti; Yuk Law; Simona Vittorini; Maura Crocetti; Marotta Marco; Bruno Murzi; Aldo Clerico
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

7.  Comparison between brain natriuretic peptide and calcitonin gene-related peptide in children with dilated cardiomyopathy and controls.

Authors:  Noor Mohammad Noori; Alireza Teimouri; Iraj Shahramian
Journal:  Niger Med J       Date:  2017 Jan-Feb

Review 8.  Factors influencing adaptation and performance at physical exercise in complex congenital heart diseases after surgical repair.

Authors:  P P Bassareo; L Saba; P Solla; C Barbanti; A R Marras; G Mercuro
Journal:  Biomed Res Int       Date:  2014-04-15       Impact factor: 3.411

9.  The Relation of Respiratory Muscle Strength to Disease Severity and Abnormal Ventilation During Exercise in Chronic Heart Failure Patients.

Authors:  Yusuke Kasahara; Kazuhiro P Izawa; Satoshi Watanabe; Naohiko Osada; Kazuto Omiya
Journal:  Res Cardiovasc Med       Date:  2015-09-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.